MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ
1.070
+0.040
+3.88%
After Hours: 1.120 +0.05 +4.67% 19:24 02/06 EST
OPEN
1.050
PREV CLOSE
1.030
HIGH
1.111
LOW
1.030
VOLUME
37.22K
TURNOVER
--
52 WEEK HIGH
6.26
52 WEEK LOW
0.9050
MARKET CAP
5.47M
P/E (TTM)
-0.4672
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDHL last week (0126-0130)?
Weekly Report · 6d ago
RedHill Biopharma Calls March 5 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
TipRanks · 01/27 12:27
Weekly Report: what happened at RDHL last week (0119-0123)?
Weekly Report · 01/26 10:06
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
TipRanks · 01/22 14:17
Weekly Report: what happened at RDHL last week (0112-0116)?
Weekly Report · 01/19 10:12
Weekly Report: what happened at RDHL last week (0105-0109)?
Weekly Report · 01/12 10:11
What's Going On With Redhill Biopharma Stock On Tuesday?
Benzinga · 01/06 15:26
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 01/06 12:05
More
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Webull offers RedHill Biopharma Ltd (ADR) stock information, including NASDAQ: RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDHL stock methods without spending real money on the virtual paper trading platform.